Angenendt L[au] - Search Results

Year	Number of Results
2015	5
2016	3
2017	2
2018	5
2019	5
2020	7
2021	7
2022	3

1

CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity.

Sauer T, Parikh K, Sharma S, Omer B, Sedloev D, Chen Q, Angenendt L, Schliemann C, Schmitt M, Müller-Tidow C, Gottschalk S, Rooney CM. Sauer T, et al. Among authors: angenendt l. Blood. 2021 Jul 29;138(4):318-330. doi: 10.1182/blood.2020008221. Blood. 2021. PMID: 34323938 Free PMC article.

2

Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells.

Larrue C, Guiraud N, Mouchel PL, Dubois M, Farge T, Gotanègre M, Bosc C, Saland E, Nicolau-Travers ML, Sabatier M, Serhan N, Sahal A, Boet E, Mouche S, Heydt Q, Aroua N, Stuani L, Kaoma T, Angenendt L, Mikesch JH, Schliemann C, Vergez F, Tamburini J, Récher C, Sarry JE. Larrue C, et al. Among authors: angenendt l. Nat Commun. 2021 Jan 18;12(1):422. doi: 10.1038/s41467-020-20717-9. Nat Commun. 2021. PMID: 33462236 Free PMC article.

3

Are formalin-fixed and paraffin-embedded tissues fit for proteomic analysis?

Bayer M, Angenendt L, Schliemann C, Hartmann W, König S. Bayer M, et al. Among authors: angenendt l. J Mass Spectrom. 2020 Aug;55(8):e4347. doi: 10.1002/jms.4347. Epub 2019 Apr 10. J Mass Spectrom. 2020. PMID: 30828905

4

Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.

Angenendt L, Hilgefort I, Mikesch JH, Schlüter B, Berdel WE, Lenz G, Stelljes M, Schliemann C. Angenendt L, et al. Ann Hematol. 2021 Jul;100(7):1871-1878. doi: 10.1007/s00277-020-04382-y. Epub 2020 Dec 19. Ann Hematol. 2021. PMID: 33341918 Free PMC article.

5

Low-density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia.

Floeth M, Elges S, Gerss J, Schwöppe C, Kessler T, Herold T, Wardelmann E, Berdel WE, Lenz G, Mikesch JH, Hartmann W, Schliemann C, Angenendt L. Floeth M, et al. Among authors: angenendt l. Br J Haematol. 2021 Feb;192(3):494-503. doi: 10.1111/bjh.16853. Epub 2020 Jun 8. Br J Haematol. 2021. PMID: 32511755

6

Calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML.

Angenendt L, Wöste M, Mikesch JH, Arteaga MF, Angenendt A, Sandmann S, Berdel WE, Lenz G, Dugas M, Meshinchi S, Schliemann C, Rössig C. Angenendt L, et al. Blood Adv. 2021 Nov 9;5(21):4413-4421. doi: 10.1182/bloodadvances.2021005236. Blood Adv. 2021. PMID: 34559198 Free PMC article.

7

Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation.

Schliemann C, Kessler T, Berdel AF, Hemmerle T, Angenendt L, Altvater B, Rossig C, Mikesch JH, Lenz G, Schäfers M, Neri D, Stelljes M, Berdel WE. Schliemann C, et al. Among authors: angenendt l. Br J Haematol. 2021 Mar;192(6):e148-e151. doi: 10.1111/bjh.17365. Epub 2021 Feb 22. Br J Haematol. 2021. PMID: 33618424 Clinical Trial. No abstract available.

8

Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas.

Schliemann C, Hemmerle T, Berdel AF, Angenendt L, Kerkhoff A, Hering JP, Heindel W, Hartmann W, Wardelmann E, Chawla SP, de Braud F, Lenz G, Neri D, Kessler T, Berdel WE. Schliemann C, et al. Among authors: angenendt l. Eur J Cancer. 2021 Jun;150:143-154. doi: 10.1016/j.ejca.2021.03.038. Epub 2021 Apr 23. Eur J Cancer. 2021. PMID: 33901793 Clinical Trial.

9

Emerging antibody-based therapies for the treatment of acute myeloid leukemia.

Angenendt L, Mikesch JH, Schliemann C. Angenendt L, et al. Cancer Treat Rev. 2022 Jul;108:102409. doi: 10.1016/j.ctrv.2022.102409. Epub 2022 May 18. Cancer Treat Rev. 2022. PMID: 35605472 Review.

10

RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations.

Brabetz O, Alla V, Angenendt L, Schliemann C, Berdel WE, Arteaga MF, Mikesch JH. Brabetz O, et al. Among authors: angenendt l. Mol Ther Nucleic Acids. 2017 Mar 17;6:243-248. doi: 10.1016/j.omtn.2016.12.012. Epub 2017 Jan 12. Mol Ther Nucleic Acids. 2017. PMID: 28325290 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results